4
Changes in Ownership
SAB Biotherapeutics, Inc. Filed Acc 0000950170-23-066395
Director acquired 4,584,571 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Moin Andrew · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-11-24 | Exercise or conversion : show line 1 in the form | +4,584,571 | 4,584,571 | I |
Table II: Derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-11-24 | Exercise or conversion : show line 2 in the form Series A-1 Convertible Preferred Stock | −31,269 | $1,000.00 | $31,269,000 | 0 | I |
| 2023-11-24 | Exercise or conversion : show line 3 in the form Series A-2 Convertible Preferred Stock | +28,380 | $1,000.00 | $28,380,000 | 28,380 | I |
Loading xslF345X05/ownership.xml…